These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 23108123)

  • 1. Feasibility of split liver transplantation for 2 adults in the model of end-stage liver disease era.
    Lee WC; Chan KM; Chou HS; Wu TJ; Lee CF; Soong RS; Wu TH; Lee CS
    Ann Surg; 2013 Aug; 258(2):306-11. PubMed ID: 23108123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes with split liver transplantation are equivalent to those with whole organ transplantation.
    Doyle MB; Maynard E; Lin Y; Vachharajani N; Shenoy S; Anderson C; Earl M; Lowell JA; Chapman WC
    J Am Coll Surg; 2013 Jul; 217(1):102-12; discussion 113-4. PubMed ID: 23639200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center.
    Agopian VG; Petrowsky H; Kaldas FM; Zarrinpar A; Farmer DG; Yersiz H; Holt C; Harlander-Locke M; Hong JC; Rana AR; Venick R; McDiarmid SV; Goldstein LI; Durazo F; Saab S; Han S; Xia V; Hiatt JR; Busuttil RW
    Ann Surg; 2013 Sep; 258(3):409-21. PubMed ID: 24022434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conventional split liver transplantation for two adult recipients: a recent experience in a single European center.
    Cescon M; Grazi GL; Ravaioli M; Ercolani G; Del Gaudio M; Vivarelli M; Cucchetti A; Zanello M; Vetrone G; Lauro A; Pinna AD
    Transplantation; 2009 Nov; 88(9):1117-22. PubMed ID: 19898208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility and Safety of Split-Liver Transplantation in a Nascent Framework of Deceased Donation.
    Cherukuru R; Reddy MS; Shanmugam NP; Rajalingam R; Kota V; Gunasekaran V; Narasimhan G; Kaliamoorthy I; Rela M
    Liver Transpl; 2019 Mar; 25(3):450-458. PubMed ID: 30586233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-MELD as a predictor of early graft mortality in adult-to-adult living-donor liver transplantation.
    Ikegami T; Imai D; Wang H; Yoshizumi T; Yamashita Y; Ninomiya M; Iguchi T; Bekki Y; Shirabe K; Maehara Y
    Transplantation; 2014 Feb; 97(4):457-62. PubMed ID: 24531822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes after liver transplantation in patients achieving a model for end-stage liver disease score of 40 or higher.
    Alexopoulos S; Matsuoka L; Cho Y; Thomas E; Sheikh M; Stapfer M; Dhanireddy K; Sher L; Selby R; Genyk Y
    Transplantation; 2013 Feb; 95(3):507-12. PubMed ID: 23380865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttransplant mortality risk assessment for adult-to-adult right-lobe living donor liver recipients with benign end-stage liver disease.
    Zhang M; Yin F; Chen B; Li Y; Yan L; Wen T; Li B
    Scand J Gastroenterol; 2012 Jul; 47(7):842-52. PubMed ID: 22546008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One hundred in situ split-liver transplantations: a single-center experience.
    Yersiz H; Renz JF; Farmer DG; Hisatake GM; McDiarmid SV; Busuttil RW
    Ann Surg; 2003 Oct; 238(4):496-505; discussion 506-7. PubMed ID: 14530721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole liver versus split liver versus living donor in the adult recipient: an analysis of outcomes by graft type.
    Humar A; Beissel J; Crotteau S; Kandaswamy R; Lake J; Payne W
    Transplantation; 2008 May; 85(10):1420-4. PubMed ID: 18497681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live donor liver transplantation in high MELD score recipients.
    Selzner M; Kashfi A; Cattral MS; Selzner N; McGilvray ID; Greig PD; Levy GA; Renner EL; Grant DR
    Ann Surg; 2010 Jan; 251(1):153-7. PubMed ID: 19858705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Living donor liver transplantation in adults in the MELD era in Germany--a multi-center retrospective analysis.
    Settmacher U; Götz M; Rahmel A; Bärthel E; Schlitt H; Puhl G; Broering D; Lehner F; Fischer L; Paul A; Schmidt J; Nadalin S; Obed A; Heise M
    Transpl Int; 2011 Sep; 24(9):904-11. PubMed ID: 21668530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor Age-Based Analysis of Liver Transplantation Outcomes: Short- and Long-Term Outcomes Are Similar Regardless of Donor Age.
    Chapman WC; Vachharajani N; Collins KM; Garonzik-Wang J; Park Y; Wellen JR; Lin Y; Shenoy S; Lowell JA; Doyle MB
    J Am Coll Surg; 2015 Jul; 221(1):59-69. PubMed ID: 25872684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Living Donation Versus Donation After Circulatory Death Liver Transplantation for Low Model for End-Stage Liver Disease Recipients.
    Kling CE; Perkins JD; Reyes JD; Montenovo MI
    Liver Transpl; 2019 Apr; 25(4):580-587. PubMed ID: 29637730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era.
    Dutkowski P; Oberkofler CE; Slankamenac K; Puhan MA; Schadde E; Müllhaupt B; Geier A; Clavien PA
    Ann Surg; 2011 Nov; 254(5):745-53; discussion 753. PubMed ID: 22042468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model for End stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) scores: Ability to predict mortality and removal from liver transplantation waiting list due to poor medical conditions.
    Rahimi-Dehkordi N; Nourijelyani K; Nasiri-Tousi M; Ghodssi-Ghassemabadi R; Azmoudeh-Ardalan F; Nedjat S
    Arch Iran Med; 2014 Feb; 17(2):118-21. PubMed ID: 24527973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction.
    Croome KP; Marotta P; Wall WJ; Dale C; Levstik MA; Chandok N; Hernandez-Alejandro R
    Transplant Proc; 2012 Jun; 44(5):1303-6. PubMed ID: 22664005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.